Biofrank Pharmaceuticals (India) Private Limited

Biofrank Pharmaceuticals (India) Private Limited - fmcg in Ambala, Haryana, India. FY 2026 financials & compliance.
CIN U24304HR2018PTC076427 Incorporated 15 October 2018 ROC Haryana HQ Ambala, Haryana, India
Active Private Limited Company FMCG MSME · Micro
Revenue · FY 2026
₹5.51 Cr
▲ 9% YoY
Net profit · FY 2026
₹92,431
Net margin 0.2%
EBITDA · FY 2026
₹9.32 Lakh
EBITDA margin 1.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹1.06 Cr
Satisfied ₹50 Lakh
Company age
8 yrs
Est. 2018
Employees · EPFO
7
Provident fund records

About Biofrank Pharmaceuticals (India) Private Limited

Data last updated:

Biofrank Pharmaceuticals (India) Private Limited is a private limited company based in Ambala, Haryana, India. It operates in the personal care and skincare products segment of the FMCG sector. It was incorporated on 15 October 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24304HR2018PTC076427. Its GSTIN is 06AAICB0708P1ZJ (Haryana).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Biofrank Pharmaceuticals Private Limited. It is led by directors Meenakshi and Munish Manchanda.

Its last annual general meeting (AGM) was held on 25 September 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Ambala, Haryana.

As per the financials filed for FY 2026, the company reported a revenue of ₹5.51 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹92,431 (net margin 0.2%) and EBITDA of ₹9.32 Lakh (EBITDA margin 1.7%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 28% over five years.

The company has about 7 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹1.06 Cr and satisfied charges of ₹50 Lakh on record.

Biofrank Pharmaceuticals (India) Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-01-0005951). For more details, the company can be reached via its website biofrankpharma.com.

Company details

CIN U24304HR2018PTC076427
Registration Number 076427
Incorporation Date 15 October 2018
ROC Haryana
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-HR-01-0005951

Recognitions & Rankings of Biofrank Pharmaceuticals (India)

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-HR-01-0005951

Contact details

Biofrank Pharmaceuticals (India) Private Limited's registered office is in Ambala, Haryana. Its website is biofrankpharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No. 78 First Floor, Jaggi Garden Phase 2, Ambala, Haryana, India – 134003
  • Industry
    FMCG, Personal Care & Skincare Products

To see the full contact details of Biofrank Pharmaceuticals (India) Private Limited, buy the company report.

Comprehensive company report
Biofrank Pharmaceuticals (India) Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Biofrank Pharmaceuticals (India) is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles46Wholesale trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Biofrank Pharmaceuticals (India) Private Limited, buy the company report.

Financials of Biofrank Pharmaceuticals (India) Private Limited

FY 2026 filings available

Biofrank Pharmaceuticals (India) Private Limited reported revenue of ₹5.51 Cr (up 9% YoY) for FY 2026.

Revenue · FY 2026
₹5.51 Cr ▲ 9%
Net profit · FY 2026
₹92,431 margin 0.2%
EBITDA · FY 2026
₹9.32 Lakh margin 1.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 22%
5 years · compounded
▲ 28%
EBITDA CAGR growth
1 year
▼ 22%

Revenue has grown at a compounded annual rate (CAGR) of 28% over five years, including 9% growth in the latest year. EBITDA fell 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations₹5.51 Cr
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹9.32 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹92,431
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin1.7%
Net Profit Margin0.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Biofrank Pharmaceuticals (India) Private Limited, buy the company report.

Board of directors of Biofrank Pharmaceuticals (India) Private Limited

Biofrank Pharmaceuticals (India) has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
MeenakshiDirector18 Apr 20242 Years 7 MonthsCurrent
Munish ManchandaDirector15 Oct 20188 Years 1 MonthsCurrent

Auditor

Biofrank Pharmaceuticals (India) Private Limited is audited by GAGANDEEP J SINGH & CO for the financial year 2026.

Auditor firmFinancial yearFirm registration number
GAGANDEEP J SINGH & COFY 2026563482

Shareholding

The shareholding of Biofrank Pharmaceuticals (India) Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2025FY 2024FY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Biofrank Pharmaceuticals (India) Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1.06 Cr
Satisfied charges
₹50 Lakh
Breakdown by lending institutions
Hdfc Bank Limited₹1.06 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
26 Jun 2026101362106Hdfc Bank Limited₹16.26 LakhOpen
21 Jan 2026101241491Hdfc Bank Limited₹90 LakhOpen
26 Sep 2024101002906State Bank of India₹50 LakhSatisfied

To see the full charge records of Biofrank Pharmaceuticals (India) Private Limited, buy the company report.

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Biofrank Pharmaceuticals (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Biofrank Pharmaceuticals (India) Private Limited has a workforce of 7 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
7
Active EPFO establishments
1

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-277
FY 2025-26

To see the full employee and EPFO history of Biofrank Pharmaceuticals (India) Private Limited, buy the company report.

GST

Biofrank Pharmaceuticals (India) has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
06AAICB0708P1ZJHaryanaActive08 Feb 2019

To see the full GST registrations and return filing status of Biofrank Pharmaceuticals (India) Private Limited, buy the company report.

Recent activity

Biofrank Pharmaceuticals (India) Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Bhanu Vadhva ceased to be Director on 25 Apr 2024.

AGM
Biofrank Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 25 Sep 2026 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 16.26 Lakh with Charge ID 101362106 was registered on 26 Jun 2026.
Filing
Biofrank Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Haryana.
Charges
A charge registered on 26 Sep 2024 via Charge ID 101002906 with State Bank Of India was fully satisfied on 06 Feb 2026.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 90.00 Lakh with Charge ID 101241491 was registered on 21 Jan 2026.
Charges
A charge with State Bank Of India amounted to Rs. 50.00 Lakh with Charge ID 101002906 was registered on 26 Sep 2024.
Ceased
Bhanu Vadhva ceased to be Director.
Appointed
Meenakshi was appointed as Director.
Ceased
Harish Kumar ceased to be Director.
Appointed
Munish Manchanda was appointed as Director.
Incorporation
15 Oct 2018
Biofrank Pharmaceuticals (India) Private Limited was registered on 15 Oct 2018 with Roc Haryana & aged 8 years 1 month as per MCA records.

Frequently asked questions

Biofrank Pharmaceuticals (India) is an active private limited company based in Ambala, Haryana, India. The company works in personal care and skincare products, within the FMCG industry. It was incorporated on 15 October 2018 (8+ years old) and is registered under CIN U24304HR2018PTC076427.

Biofrank Pharmaceuticals (India) has 2 current directors:

The latest financial statements of Biofrank Pharmaceuticals (India) on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 25 September 2026. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Biofrank Pharmaceuticals (India) is 06AAICB0708P1ZJ, registered in Haryana.

The CIN (Corporate Identification Number) of Biofrank Pharmaceuticals (India) is U24304HR2018PTC076427. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Biofrank Pharmaceuticals (India) was incorporated on 15 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Haryana.

Bhanu Vadhva ceased to be Director on 25 Apr 2024. Meenakshi was appointed as Director on 18 Apr 2024. Harish Kumar ceased to be Director on 31 Mar 2021. Biofrank Pharmaceuticals (India) has 4 board changes on record in total.

Yes, Biofrank Pharmaceuticals (India) is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-01-0005951).

Biofrank Pharmaceuticals (India) can be reached through the website biofrankpharma.com. Its registered office is in Ambala, Haryana, India.

The registered office of Biofrank Pharmaceuticals (India) is at Plot No. 78 First Floor, Jaggi Garden Phase 2, Ambala, Haryana, India – 134003.